Moors & Cabot’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.4M Sell
120,078
-1,508
-1% -$351K 1.26% 11
2025
Q4
$25.2M Sell
121,586
-279
-0.2% -$55.2K 1.08% 10
2025
Q3
$22.6M Sell
121,865
-4,551
-4% -$780K 0.99% 13
2025
Q2
$19.3M Buy
126,416
+4,257
+3% +$654K 0.9% 16
2025
Q1
$20.3M Sell
122,159
-1,997
-2% -$312K 1.03% 15
2024
Q4
$18M Sell
124,156
-1,220
-1% -$189K 0.85% 17
2024
Q3
$20.3M Buy
125,376
+93
+0.1% +$14.8K 1.01% 13
2024
Q2
$18.3M Sell
125,283
-1,649
-1% -$245K 0.98% 15
2024
Q1
$20.1M Buy
126,932
+7,154
+6% +$1.14M 1.09% 13
2023
Q4
$18.8M Buy
119,778
+2,681
+2% +$411K 1.17% 9
2023
Q3
$18.2M Sell
117,097
-976
-0.8% -$161K 1.24% 10
2023
Q2
$19.5M Sell
118,073
-345
-0.3% -$55.7K 1.3% 8
2023
Q1
$18.4M Sell
118,418
-3,165
-3% -$511K 1.26% 8
2022
Q4
$21.5M Sell
121,583
-1,937
-2% -$334K 1.5% 5
2022
Q3
$20.2M Sell
123,520
-6,159
-5% -$1.04M 1.54% 5
2022
Q2
$23M Buy
129,679
+2,236
+2% +$398K 1.66% 4
2022
Q1
$22.6M Buy
127,443
+3,922
+3% +$667K 1.39% 6
2021
Q4
$21.1M Sell
123,521
-583
-0.5% -$95.4K 1.3% 9
2021
Q3
$20M Sell
124,104
-947
-0.8% -$162K 1.26% 10
2021
Q2
$20.6M Buy
125,051
+2,696
+2% +$446K 1.44% 5
2021
Q1
$20.1M Sell
122,355
-3,164
-3% -$512K 1.54% 5
2020
Q4
$19.8M Sell
125,519
-2,535
-2% -$374K 1.66% 4
2020
Q3
$19.1M Buy
128,054
+8,202
+7% +$1.21M 1.79% 4
2020
Q2
$16.9M Buy
119,852
+17,974
+18% +$2.62M 1.8% 4
2020
Q1
$13.4M Sell
101,878
-13,969
-12% -$1.98M 1.94% 4
2019
Q4
$16.9M Buy
115,847
+1,735
+2% +$235K 1.7% 5
2019
Q3
$14.8M Sell
114,112
-8,885
-7% -$1.17M 1.63% 6
2019
Q2
$17.1M Buy
122,997
+2,955
+2% +$409K 2.17% 3
2019
Q1
$16.8M Sell
120,042
-11,394
-9% -$1.53M 2.28% 3
2018
Q4
$17M Sell
131,436
-7,790
-6% -$1.09M 2.66% 1
2018
Q3
$19.3M Buy
139,226
+3,882
+3% +$516K 2.35% 2
2018
Q2
$16.4M Sell
135,344
-2,985
-2% -$372K 2.21% 2
2018
Q1
$17.7M Buy
138,329
+4,259
+3% +$576K 2.34% 1
2017
Q4
$18.7M Buy
134,070
+7,285
+6% +$1.01M 2.48% 1
2017
Q3
$16.5M Buy
126,785
+16,504
+15% +$2.19M 2.39% 1
2017
Q2
$14.6M Sell
110,281
-177
-0.2% -$22.6K 2.42% 1
2017
Q1
$13.7M Sell
110,458
-3,546
-3% -$424K 2.32% 1
2016
Q4
$13.2M Buy
114,004
+734
+0.6% +$84.8K 2.17% 3
2016
Q3
$13.4M Buy
113,270
+4,717
+4% +$572K 2.24% 1
2016
Q2
$13.1M Sell
108,553
-3,732
-3% -$424K 2.31% 2
2016
Q1
$12.1M Buy
112,285
+306
+0.3% +$31.7K 2.19% 3
2015
Q4
$11.5M Sell
111,979
-4,068
-4% -$409K 2.11% 3
2015
Q3
$10.8M Buy
116,047
+1,799
+2% +$174K 2% 2
2015
Q2
$11.1M Sell
114,248
-1,848
-2% -$185K 1.81% 4
2015
Q1
$11.7M Buy
116,096
+54
+0% +$5.49K 1.94% 3
2014
Q4
$12.1M Sell
116,042
-1,065
-0.9% -$112K 2.05% 3
2014
Q3
$12.5M Buy
117,107
+2,160
+2% +$224K 2.12% 3
2014
Q2
$12M Buy
114,947
+6,130
+6% +$620K 2.02% 3
2014
Q1
$10.7M Buy
+108,817
New +$10.1M 2.7% 2

Other funds holding JNJ

Moors & Cabot's JNJ Position: Q1 2026 in Review

Moors & Cabot reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q1 2026, selling an estimated $351K and leaving 120,078 shares worth $29.4M. The position accounts for 1.26% of the portfolio, ranked #11.

Moors & Cabot first reported a position in JNJ in Q1 2014 and has held it in 49 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Moors & Cabot held 120,078 shares of Johnson & Johnson worth $29.4M as of Q1 2026.
  • Moors & Cabot sold 1,508 Johnson & Johnson shares in Q1 2026, an estimated $351K.
  • Johnson & Johnson made up 1.26% of Moors & Cabot's portfolio in Q1 2026, its #11 holding.
  • Moors & Cabot first reported a position in Johnson & Johnson in Q1 2014 and has held it in 49 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.